» Articles » PMID: 18649336

HIV-1 Triggers Apoptosis in Primary Osteoblasts and HOBIT Cells Through TNFalpha Activation

Overview
Journal J Med Virol
Specialty Microbiology
Date 2008 Jul 24
PMID 18649336
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Several HIV-1 infected patients show bone loss and osteopenia/osteoporosis during the course of disease. The mechanisms underlying this degenerative process are largely unsettled and it has not been determined yet whether bone dysfunction is linked to HIV-1-mediated direct and/or indirect effects on osteoblasts/osteoclasts cross-talk regulation. This study investigated the effects of HIV-1(IIIb) and HIV-1(ADA) strains on osteoblasts using the osteoblast-derived cell line (HOBIT) and primary human osteoblasts as cellular models. The challenge of these cell cultures by both HIV-1 strains triggered a significant apoptosis activation unrelated to viral infection, since proviral HIV-1 DNA and supernatant HIV-1 RNA were not detected by real time PCR or b-DNA assays respectively. Under the experimental conditions, even heat-inactivated HIV-1 or cross-linked recombinant gp120 treatment of HOBIT and osteoblasts induced programmed cell death, suggesting that apoptosis is regulated by the interaction between HIV-1 gp120 and cell membrane. The analysis of cell culture supernatants showed a significant up-regulation of TNFalpha, a pleiotropic protein considered an apoptosis inducer in the osteoblast model. In fact, pretreatment of HOBIT and osteoblast cell cultures with anti-TNFalpha polyclonal antibody tackled effectively HIV-1 related induction of cell apoptosis. As a whole, these results indicate that HIV-1 may impair bone mass structure homeostasis by TNFalpha regulated osteoblast apoptosis.

Citing Articles

Evaluation of bone mineral density and its influencing factors in patients infected with HIV under antiretroviral therapy.

Azarboo A, Hemmatabadi M, Fahimfar N, Faghihi Z, SeyedAlinaghi S, Shirzad N BMC Infect Dis. 2025; 25(1):33.

PMID: 39762767 PMC: 11706035. DOI: 10.1186/s12879-024-10388-y.


Chitosan biomineralized with ions-doped nano-hydroxyapatite tunes osteoblasts metabolism and DNA damage.

Furlani F, Malfatti M, Rondinella A, Campodoni E, Sandri M, Fedrizzi L J Biol Eng. 2024; 18(1):60.

PMID: 39456111 PMC: 11515322. DOI: 10.1186/s13036-024-00458-9.


HIV Modulates Osteoblast Differentiation via Upregulation of RANKL and Vitronectin.

Freiberger R, Lopez C, Palma M, Cevallos C, Sviercz F, Jarmoluk P Pathogens. 2024; 13(9).

PMID: 39338991 PMC: 11435243. DOI: 10.3390/pathogens13090800.


Bone Tissue Changes in Individuals Living with HIV/AIDS: The Importance of a Hierarchical Approach in Investigating Bone Fragility.

Jadzic J, Dragovic G, Lukic R, Obradovic B, Djuric M J Pers Med. 2024; 14(8).

PMID: 39201983 PMC: 11355540. DOI: 10.3390/jpm14080791.


Consequences of HIV infection in the bone marrow niche.

Herd C, Mellet J, Mashingaidze T, Durandt C, Pepper M Front Immunol. 2023; 14:1163012.

PMID: 37497228 PMC: 10366613. DOI: 10.3389/fimmu.2023.1163012.